C. Wu and J. Yang, “Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer”, World J Oncol, vol. 17, no. 3, pp. 347–356, Jan. 2026, doi: 10.14740/wjon2727.